UAB startup TIXiMED advances TIX100, a novel oral Type 1 diabetes therapy, into Phase 1b clinical testing. The ...
Over the past few years, several innovations have crossed important milestones, moving from experimental ...
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...